-
Sweeping new changes have been made to the guidelines for prevention of endocarditis in patients undergoing dental procedures.
-
A low-glycemic load diet is more likely to produce weight loss in obese young adults who have high insulin concentrations than is a low fat diet; it is also more likely to improve high-density lipoproteins (HDL) and triglycerides, regardless of insulin levels.
-
The spectrum of nonalcoholic fatty liver disease (NAFLD) can range from asymptomatic accumulation of fat in the liver without inflammation, to non-alcoholic Steatohepatitis (NASH).
-
Intensive intervention using Advance Practice Nurses reduced the use of side rails on nursing home beds and lowered the rate of bed-related falls and injuries.
-
Occipital nerve stimulation appears to decrease the cluster pain and attack frequency in most, but not all, patients with chronic drug-resistant cluster headaches.
-
Hospital legends about the relative availability (or unavailability) of services/personnel on weekends vs weekdays often lead to jocularity about the wisdom of choosing one's day to be admitted to the hospital carefully!
-
There is a surge of coronary deaths following influenza epidemics, which strengthens the importance of flu vaccinations for those at risk for cardiovascular events.
-
High dose PPI infusion prior to endoscopy accelerated resolution of the signs of ulcer bleeding and significantly reduced the need for endoscopic hemostasis therapy.
-
Quinolone-resistant neisseria gonorrhea (QRNG) continues to spread with alarming frequency across the United States. Quinolones were first recommended for the treatment of GC by the CDC in 1986.
-
The FDA has approved a new combination product for the treatment of type 2 diabetes mellitus. Sitagliptin, the recently approved dipeptidyl peptidase-4 (DPP-4) inhibitor is combined with metformin in two different dose configurations. Sitagliptin/metformin is marketed by Merck & Co., Inc as Janumet.
